These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

974 related items for PubMed ID: 30100243

  • 1. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
    Monteillet L, Gjorgjieva M, Silva M, Verzieux V, Imikirene L, Duchampt A, Guillou H, Mithieux G, Rajas F.
    Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
    [Abstract] [Full Text] [Related]

  • 2. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M, Calderaro J, Monteillet L, Silva M, Raffin M, Brevet M, Romestaing C, Roussel D, Zucman-Rossi J, Mithieux G, Rajas F.
    J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting.
    Kaneko K, Soty M, Zitoun C, Duchampt A, Silva M, Philippe E, Gautier-Stein A, Rajas F, Mithieux G.
    Mol Metab; 2018 Oct; 16():203-212. PubMed ID: 29960865
    [Abstract] [Full Text] [Related]

  • 6. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
    Yavarow ZA, Kang HR, Waskowicz LR, Bay BH, Young SP, Yen PM, Koeberl DD.
    Hum Mol Genet; 2020 Jan 15; 29(2):286-294. PubMed ID: 31816064
    [Abstract] [Full Text] [Related]

  • 7. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
    Farah BL, Landau DJ, Sinha RA, Brooks ED, Wu Y, Fung SYS, Tanaka T, Hirayama M, Bay BH, Koeberl DD, Yen PM.
    J Hepatol; 2016 Feb 15; 64(2):370-379. PubMed ID: 26462884
    [Abstract] [Full Text] [Related]

  • 8. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y, Hoogerland JA, Bloks VW, Bos T, Bleeker A, Wolters H, Wolters JC, Hijmans BS, van Dijk TH, Thomas R, van Weeghel M, Mithieux G, Houtkooper RH, de Bruin A, Rajas F, Kuipers F, Oosterveer MH.
    Hepatology; 2020 Nov 15; 72(5):1638-1653. PubMed ID: 32083759
    [Abstract] [Full Text] [Related]

  • 9. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas.
    Mutel E, Abdul-Wahed A, Ramamonjisoa N, Stefanutti A, Houberdon I, Cavassila S, Pilleul F, Beuf O, Gautier-Stein A, Penhoat A, Mithieux G, Rajas F.
    J Hepatol; 2011 Mar 15; 54(3):529-37. PubMed ID: 21109326
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
    Hijmans BS, Boss A, van Dijk TH, Soty M, Wolters H, Mutel E, Groen AK, Derks TGJ, Mithieux G, Heerschap A, Reijngoud DJ, Rajas F, Oosterveer MH.
    Hepatology; 2017 Dec 15; 66(6):2042-2054. PubMed ID: 28727166
    [Abstract] [Full Text] [Related]

  • 15. Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.
    Clar J, Gri B, Calderaro J, Birling MC, Hérault Y, Smit GP, Mithieux G, Rajas F.
    Kidney Int; 2014 Oct 15; 86(4):747-56. PubMed ID: 24717294
    [Abstract] [Full Text] [Related]

  • 16. Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.
    Hoogerland JA, Peeks F, Hijmans BS, Wolters JC, Kooijman S, Bos T, Bleeker A, van Dijk TH, Wolters H, Gerding A, van Eunen K, Havinga R, Pronk ACM, Rensen PCN, Mithieux G, Rajas F, Kuipers F, Reijngoud DJ, Derks TGJ, Oosterveer MH.
    J Inherit Metab Dis; 2021 Jul 15; 44(4):879-892. PubMed ID: 33739445
    [Abstract] [Full Text] [Related]

  • 17. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT, Lu FH, Ou HY, Su YC, Hung HC, Wu JS, Yang YC, Wu CL, Chang CJ.
    J Hepatol; 2013 Nov 15; 59(5):1065-72. PubMed ID: 23792031
    [Abstract] [Full Text] [Related]

  • 18. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
    Zhou J, Waskowicz LR, Lim A, Liao XH, Lian B, Masamune H, Refetoff S, Tran B, Koeberl DD, Yen PM.
    Thyroid; 2019 Aug 15; 29(8):1158-1167. PubMed ID: 31337282
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE, Renquist BJ.
    J Endocrinol; 2017 Jul 15; 234(1):R1-R21. PubMed ID: 28428362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.